Not exact matches
Panoskaltsis - Mortari's team has been working on rebuilding
lungs and other parts
of the respiratory system using human
stem cells.
MIMICKING the environment experienced by
cells in the windpipe is enough to transform
stem cells into a range
of different
lung cells.
Many scientists believe that targeting a type
of cell called a cancer
stem cell may be necessary to completely cure
lung cancer.
Using a mathematical model known as the Ising model, invented to describe phase transitions in statistical physics, such as how a substance changes from liquid to gas, the Johns Hopkins researchers calculated the probability distribution
of methylation along the genome in several different human
cell types, including normal and cancerous colon,
lung and liver
cells, as well as brain, skin, blood and embryonic
stem cells.
A new study has found that
stem cell therapy can reduce
lung inflammation in an animal model
of chronic obstructive pulmonary disease (COPD) and cystic fibrosis.
«Potential
of stem cell therapy to repair
lung damage.»
Loss
of either GSTO1 or RYR1, the researchers report, decreased the number
of cancer
stem cells in the primary tumor, blocked metastasis
of cancer
cells from the primary tumor to the
lungs, decreased the duration
of chemotherapy required to induce remission and increased the duration
of time after chemotherapy was stopped that the mice remained tumor - free.
Previously,
stem cells have been made to differentiate into
lung cells using a cocktail
of different growth factors, but Haute says using physical forces might be simpler.
Now, scientists at Boston University's Center for Regenerative Medicine (CReM) have announced two major findings that further our understanding
of this process: the ability to grow and purify the earliest
lung progenitors that emerge from human
stem cells, and the ability to differentiate these
cells into tiny «bronchospheres» that model cystic fibrosis.
But with humans, she is using iPS
cells and has been working to develop the correct protocols to induce her
stem cells to differentiate into different kinds
of lung tissue.
Human
lungs, like all organs, begin their existence as clumps
of undifferentiated
stem cells.
Researchers hope that the results, published separately in the Journal
of Clinical Investigation and
Cell Stem Cell, will lead to new, «personalized medicine» approaches to treating
lung disease.
«If you look at a set
of lung cancer patients, like we did in the paper, who develop brain metastases, they all have those two genes in their primary
lung cancer,» said Sheila Singh, the study's supervisor, associate professor at the Michael G. DeGroote School
of Medicine, scientist with the
Stem Cell and Cancer Research Institute at McMaster University and neurosurgeon at McMaster Children's Hospital.
• A Yale research team led by Diane Krause turned a single
stem cell from the bone marrow
of an adult mouse into
lung, liver, intestinal, and skin
cells for other mice.
«We found that many more mice developed tumors when given the
cells that we had engineered to have these
stem cell characteristics, and they had a much higher incidence
of metastasis in the
lungs,» Kilian said.
What's really impressive about Babar's accomplishment is that he did the work for both papers — one on the role
of a population
of stem cells in
lung cancer development (published in
Cell) the other on gene expression in group A Streptococcus (published in PNAS)-- as a participant in summer undergraduate research programs.
«The introduction
of mitochondria into damaged
cells has beneficial effects on the health
of cells and, in the long term, we believe that mesenchymal
stem cells could even be engineered to create more effective therapies for
lung disease in humans.»
A research team has identified a protein that increases the transfer
of mitochondria from mesenchymal
stem cells to
lung cells.
The trial, published in Circulation Research, was designed to test the feasibility and side effects
of a genetically - enhanced
stem cell therapy to repair and regenerate
lung blood vessels in PAH.
The treatment is promising enough that research teams around the world are developing similar
stem cell therapies that can target and eradicate cancers
of the prostate,
lung, breast, skin and other tissues.
«Study finds cause
of pulmonary fibrosis in failure
of stem cells that repair
lungs.»
The
stem cells that proliferate the most in response to damage caused by cigarette smoke repair their DNA using a process prone to errors, setting the stage for
lung cancer, according to a study publishing January 26, 2017 in the open - access journal PLOS Biology by Marie - Liesse Asselin - Labat and her team
of the Walter and Eliza hall Institute
of Medical Research, Australia.
These proteins are crucial for tissue healing by instructing various processes, including the activation
of specific
stem cell populations, ensuring that
lung tissue can be restored to its original condition.
«The information we have gained about the dynamic changes in ECM composition and its interactions with various secreted growth factor proteins enables us to develop new hypotheses for the activation
of stem cells in the
lung,» explains Dr. Herbert Schiller, first author
of the study.
Harvard
Stem Cell Institute scientists at Brigham and Women's Hospital have found the cellular origin
of the tissue scarring caused by organ damage associated with diabetes,
lung disease, high blood pressure, kidney disease, and other conditions.
Induced pluripotent
stem cells are a type
of pluripotent
stem cell that can be generated directly from adult
cells; they have the ability to be differentiated into a variety
of tissue types and, in this case, MSCs that can regenerate damaged
lung tissue.
In the case
of gene editing, Verma is creating induced pluripotent
stem cells (iPSCs) from patients by taking, for example, skin
cells of patients, coaxing them back into an early
stem cell state, and then providing conditions to make those
cells develop into more complex brain,
lung, prostate and breast tissues.
She studies the process
of cancer initiation and progression along with cancer
stem cells, the evolution
of drug resistance and the dynamics
of metastasis formation focusing on
lung, brain, breast and pancreatic cancers.
If the marriage
of stem cells and CRISPR follows a similar path, it might not be long before pigs have enough Homo sapiens in them not only to grow human hearts,
lungs, livers, and kidneys for transplant but also to model human diseases more closely than current lab animals do and to test experimental drugs.
Impact
of bone marrow - derived mesenchymal
stem cells on remodeling the
lung injury induced by lipopolysaccharides in mice Mouchira M Mohi El - Din, Laila A Rashed, Mohi A Mahmoud Haridy, Atef Mohamed Khalil, Mohamed A Mohamed Albadry.
$ 1.8 M Supports Cancer Drug Discovery on Commonly Mutated Gene New Brunswick Patch — April 5, 2016 Behavioral Scientist Shares Insights about FDA's Proposed Rule on Banning Tanning Bed Use among Minors News-Medical.net - March 19, 2016 Intervention Program Reduces Caregiver Distress during Hospitalization
of Pediatric
Stem Cell Transplant Patients News-Medical.net - March 9, 2016 Exploring Genomic Pathways in the Development
of Ovarian Cancer GMNews.com - March 2, 2016 Differences in Type
of Small Protein may further Elucidate
Lung Cancer Risk in African Americans ScienceDaily.com - March 2, 2016 Study Looks at Post-Treatment Resources for Prostate Cancer Patients Transitioning to Survivorship News-Medical.net - February 11, 2016 Drawing the Line on Tanning Bed Use by Teens ScienceDaily.com - December 21, 2015 What Rutgers Study Uncovered about E-Cigarette Use NJBiz.com - December 9, 2015 Identification
of Barrier that Prevents Progression
of Benign Kidney Tumors to Malignant Disease MedicalNewsToday.com - November, 24, 2015 What is the Color
of the
Lung Cancer Ribbon?
Wnt blockers inhibit the proliferation
of lung cancer
stem cells.
Pre-clinical evidence concerning the utility
of mesenchymal
stem cells (MSCs) to aid the treatment
of acute
lung injury (ALI) has been mounting over recent years, with some clinical trials beginning to run.
Therapeutic potential
of adipose
stem cell - derived conditioned medium against pulmonary hypertension and
lung fibrosis.
The most common form
of lung cancer may begin in a group
of newly isolated
lung stem cells, according to researchers from the Howard Hughes Medical Institute.
Until now, blood
cell production was ascribed solely to bone marrow, but studies on mice have found that the majority
of the body's platelets are produced in the
lungs, as is a backup reservoir
of blood
stem cells that can step in when those in the bone marrow run dry.
Scientists need to prompt
stem cells to become kidney, liver or
lung cells, which must then recreate the complex anatomy
of a real organ in order to function in a human recipient.
Cedars - Sinai scientists can harvest
cells from the blood or skin
of an individual and reprogram them into induced pluripotent
stem cells, which can be made into any organ
cell (such as those from the
lung, liver or intestine), each bearing the unique genetic fingerprint and characteristics
of the person.
Examples include a series
of studies to document persistent microchimerism
of donor
cells in transfusion recipients, with particular focus on mechanisms and clinical relevance
of donor
stem cell microchimerism in transfused trauma patients, and the immunological mechanisms and prevention
of transfusion - related acute
lung injury (TRALI) and alloimmunization.
March 6, 2018 — Researchers identified a type
of stem cell that produces new air sac
cells in
lung tissue.
In 2014, the National Institutes
of Health helped to fund the first
of its kind
lung stem cell repository, which provides researchers open (free) access to the different types
of induced pluripotent
lung cells to use in their laboratories.
A team
of scientists from the UNC School
of Medicine and North Carolina State University (NCSU) has developed promising research towards a possible
stem cell treatment for several
lung conditions, such as idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), and cystic fibrosis — often - fatal conditions that affect tens
of millions
of Americans.
In the long run, the scientists hope their
lung stem cell therapy will also help patients with other
lung fibrosis conditions
of which there are dozens, including COPD, cystic fibrosis, and fibro - cavernous pulmonary tuberculosis.
Scientists have been studying the alternative possibility
of using
stem cells to treat IPF and other
lung fibrosis diseases.
The Center for Regenerative Medicine (CReM) at Boston University and Boston Medical Center has engineered two new categories
of lung epithelial
cells in vitro using pluripotent
stem cells.
Bone Marrow — Derived Mesenchymal
Stem Cells in Repair
of the Injured
Lung (October, 2004) in American Journal
of Respiratory
Cell and Molecular Biology.
In a second study, published in the journal
Stem Cells Translational Medicine, the team showed that in rodents they could use the same type
of lung cell to successfully treat a model
of IPF — a chronic, irreversible, and ultimately fatal disease characterized by a progressive decline in
lung function.
«This is the first time anyone has generated potentially therapeutic
lung stem cells from minimally invasive biopsy specimens,» said co-senior author
of both papers Jason Lobo, MD, an assistant professor
of medicine at UNC and medical director
of lung transplant and interstitial
lung disease.Co - senior author Ke Cheng, PhD, an associate professor in NCSU's Department
of Molecular Biomedical Sciences and the UNC / NCSU Joint Department
of Biomedical Engineering, said, «We think the properties
of these
cells make them potentially therapeutic for a wide range
of lung fibrosis diseases.»
Although your
lungs possess their own population
of healing adult
stem cells, there are simply not enough
cells present to keep up with the degree
of ongoing
lung tissue damage which occurs in COPD.
Stem Cell Therapy company presents a collection of stem cell - based therapy summaries for multiple diseases such as diabetes, liver disease, lung disease, osteoarthritis and m
Stem Cell Therapy company presents a collection of stem cell - based therapy summaries for multiple diseases such as diabetes, liver disease, lung disease, osteoarthritis and m
Cell Therapy company presents a collection
of stem cell - based therapy summaries for multiple diseases such as diabetes, liver disease, lung disease, osteoarthritis and m
stem cell - based therapy summaries for multiple diseases such as diabetes, liver disease, lung disease, osteoarthritis and m
cell - based therapy summaries for multiple diseases such as diabetes, liver disease,
lung disease, osteoarthritis and more.